On Thursday it was announced that a patient in Austria was in hospital after using a counterfeit diabetes drug (Ozempic). Now further details are known.
As already reported, a patient in Austria has to be treated in a hospital after taking a counterfeit diabetes drug (“Ozempic”). The Federal Office for the Safety of the Healthcare System (BASG) has provided information about this. In addition, counterfeits of the diabetes pen are said to have already reached patients in Austria. The BASG also believes there are other counterfeits that are difficult or impossible to detect, it warned.
The BASG added that there was a serious adverse event involving hypoglycemia and seizures. This is an indication “that the product incorrectly contained insulin instead of the active substance semaglutide”, according to an added broadcast on Thursday evening.
Some “serious symptoms”
The BASG emphasized that when “treating potential clinical cases” the side effects due to insulin overdose or resulting hypoglycemia with sometimes severe symptoms should also be taken into account. It is not yet clear where the person got the medicines from.
There is no evidence that the counterfeit products were dispensed to patients by legitimate pharmacies. The BASG warns “strongly and urgently against any unauthorized ordering of ‘Ozempic’ on the internet”.
Source: Krone
I am Wallace Jones, an experienced journalist. I specialize in writing for the world section of Today Times Live. With over a decade of experience, I have developed an eye for detail when it comes to reporting on local and global stories. My passion lies in uncovering the truth through my investigative skills and creating thought-provoking content that resonates with readers worldwide.
